MatsukiyoCocokara & Co.
General ticker "MSMKF" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $7.1B (TTM average)
MatsukiyoCocokara & Co. follows the US Stock Market performance with the rate: 28.1%.
Estimated limits based on current volatility of 0.0%: low 18.17$, high 18.17$
Factors to consider:
- Earnings expected soon, date: 2026-02-12 bmo
- Company pays dividends (annually): last record date 2025-09-30, amount 0.16$ (Y0.88%)
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [12.65$, 20.74$]
- 2025-03-31 to 2026-03-31 estimated range: [12.54$, 20.78$]
Financial Metrics affecting the MSMKF estimates:
- Positive: with PPE of 20.0 at the end of fiscal year the price was low
- Positive: -5.04 < Operating profit margin, % of 7.40
- Positive: Industry inventory ratio change (median), % of -0.78 <= -0.18
- Positive: -9.11 < Industry operating profit margin (median), % of -8.27
- Negative: negative Industry operating cash flow (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.74 > 6.11
- Negative: Investing cash flow per share per price, % of -2.10 <= -0.63
Short-term MSMKF quotes
Long-term MSMKF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 |
|---|---|---|
| Operating Revenue | ¥951,247.00MM | ¥1,022,531.00MM |
| Operating Expenses | ¥888,971.00MM | ¥946,826.00MM |
| Operating Income | ¥62,276.00MM | ¥75,705.00MM |
| Non-Operating Income | ¥2,632.00MM | ¥5,541.00MM |
| Interest Expense | ¥53.00MM | ¥57.00MM |
| Income(Loss) | ¥64,908.00MM | ¥81,246.00MM |
| Taxes | ¥24,141.00MM | ¥28,630.00MM |
| Profit(Loss)* | ¥40,545.00MM | ¥52,347.00MM |
| Stockholders Equity | ¥482,470.00MM | ¥514,727.00MM |
| Inventory | ¥136,480.00MM | ¥139,352.00MM |
| Assets | ¥688,132.00MM | ¥724,747.00MM |
| Operating Cash Flow | ¥64,061.00MM | ¥63,506.00MM |
| Capital expenditure | ¥16,746.00MM | ¥20,113.00MM |
| Investing Cash Flow | ¥-19,669.00MM | ¥-22,760.00MM |
| Financing Cash Flow | ¥-23,734.00MM | ¥-18,273.00MM |
| Earnings Per Share** | ¥96.02 | ¥125.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.